Meet our awardees! #TOComplement2022
@FerraNeto from #HospitalMariaAparecidaPedrossian #Brazil 馃嚙馃嚪 @Alanepe1
Best #CaseReport Award 馃弲
Excellent presentation of an #aHUS and Acute Difusse #Glomerulonephritis
Earning $500 CAD Congratulations!
Meet our awardees! #TOComplement2022
#HayeongRho from
@UofT
Third place! 馃 #ClinicalResearch
Wonderful presentation on excellence on accessibility services for #ParoxysmalNocturnalHemoglobinuria #PNH
Earning $1,000 CAD third price
Congratulations!
Meet our awardees! #TOComplement2022
#FahadHannan from @WesternU Second place! 馃 #TraslationalResearch
Amazing presentation on #ThromboticThrombocytopenicPurpura #TTP and impact in #Neurocognitive
Earning $1,500 CAD second price
Congratulations!
Meet our awardees! #TOComplement2022
@drvalebruno from @SickKidsNews First place! 馃 #BasicScience
Outstanding presentation on the role of #Complement in Primary #MembranousNephropathy
Earning $2,000 CAD first price
Congratulations #ValentinaBruno!
Excellent closure of the #TOComplement2022 with our
Speakers #SeppoMeri #RichardCoward @dmastellos
Co-chairs @CPQMD #ChristophLicht and
The #YoungInvestigarosForum Awardees! 馃@drvalebruno馃#FahadHannan馃#HayeongRho and #OresteFerra
See you all next year!
#ILoveComplement 鉂わ笍
Excellent Panel discussion about #Complement at the #TOComplement2022 with outstanding #Scientists
#DrSeppoMeri @helsinkiuni 馃嚝馃嚠
#DrRichardCoward @BristolUni 馃嚞馃嚙
@dmastellos @NCSR_Demokritos 馃嚞馃嚪
#ILoveComplement 鉂わ笍
Replying to @dmastellos
@dmastellos from @NCSR_Demokritos teaching about --The "dawn" of clinical complement #C3 inhibition. Emerging opportunities and challenges- at #TOComplement2022
#ILoveComplement 鉂わ笍 #RareDiseases
#DrRichardCoward @BristolUni sharing research on "The #Podocyte and #Shigatoxin induced #HUS " at the #TOComplement2022
#ILoveComplement 鉂わ笍
Excellent Q&A session with #DrSeppoMeri at #TOComplement2022
#DrSeppoMeri @helsinkiuni beutifully teaching about "Cellular Responses to Complement Activation" at #TOComplement2022
#ILoveComplement 鉂わ笍
















